Electrofisiología Cardíaca Celular

Crespo-Garcia, T; Camara-Checa, A; Dago, M; Rubio-Alarcon, M; Rapun, J; Tamargo, J; Delpon, E; Caballero, R.

Regulation of cardiac ion channels by transcription factors: Looking for new opportunities of druggable targets for the treatment of arrhythmias

BIOCHEMICAL PHARMACOLOGY. 2022; 204: Nº de citas: 7 [doi:10.1016/j.bcp.2022.115206]

Tamargo, J; Kaski, JC; Kimura, T; Barton, JC; Yamamoto, K; Komiyama, M; Drexel, H; Lewis, BS; Agewall, S; Hasegawa, K.

Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events

European Heart Journal-Cardiovascular Pharmacotherapy. 2022; 8(7): 738-751 Nº de citas: 47 [doi:10.1093/ehjcvp/pvac040]

Tamargo, J; Kjeldsen, KP; Delpon, E; Semb, AG; Cerbai, E; Dobrev, D; Savarese, G; Sulzgruber, P; Rosano, G; Borghi, C; Wassman, S; Torp-Pedersen, CT; Agewall, S; Drexel, H; Baumgartner, I; Lewis, B; Ceconi, C; Kaski, JC; Niessner, A.

Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

European Heart Journal-Cardiovascular Pharmacotherapy. 2022; 8(4): 406-419 Nº de citas: 46 [doi:10.1093/ehjcvp/pvac005]

Alvarez-Baena, L; Hervias, M; Ramos, S; Cebrian, J; Pita, A; Hidalgo, I.

Continuous thoracic paravertebral analgesia after minimally invasive atrial septal defect closure surgery in pediatric population: Effectiveness and safety analysis

Revista Espanola de Anestesiologia y Reanimacion. 2022; 69(5): 259-265 Nº de citas: 4 [doi:10.1016/j.redar.2021.05.024]

Ruilope LM; Ruiz-Hurtado G; Tamargo J.

Editorial commentary: Adequate blood pressure control unattainable without adequate recognition and treatment of primary aldosteronism

TRENDS IN CARDIOVASCULAR MEDICINE. 2022; 32(4): 234-236 Nº de citas: 4 [doi:10.1016/j.tcm.2021.04.003]

Flores, CH; Diez-Delhoyo, F; Sanz-Ruiz, R; Vazquez-Alvarez, ME; Delpon, MT; Triguero, JS; Corrales, JE; Fernandez-Aviles, F; Ibanes, EG.

Microvascular dysfunction of the non-culprit circulation predicts poor prognosis in patients with ST-segment elevation myocardial infarction

IJC HEART & VASCULATURE. 2022; 39: Nº de citas: 5 [doi:10.1016/j.ijcha.2022.100997]

Triska, J; Tamargo, J; Bozkurt, B; Elkayam, U; Taylor, A; Birnbaum, Y.

An Updated Review on the Role of Non-dihydropyridine Calcium Channel Blockers and Beta-blockers in Atrial Fibrillation and Acute Decompensated Heart Failure: Evidence and Gaps

CARDIOVASCULAR DRUGS AND THERAPY. 2022; 37(6): 1205-1223 Nº de citas: 5 [doi:10.1007/s10557-022-07334-y]

Nieto-Marin, P; Tinaquero, D; Utrilla, RG; Cebrian, J; Gonzalez-Guerra, A; Crespo-Garcia, T; Camara-Checa, A; Rubio-Alarcon, M; Dago, M; Alfayate, S; Filgueiras, D; Peinado, R; Lopez-Sendon, JL; Jalife, J; Tamargo, J; Bernal, JA; Caballero, R; Delpon, E; ITACA Consortium Investigators.

Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome

CARDIOVASCULAR RESEARCH. 2022; 118(4): 1046-1060 Nº de citas: 26 [doi:10.1093/cvr/cvab045]

El Hadidi, S; Rosano, G; Tamargo, J; Agewall, S; Drexel, H; Kaski, JC; Niessner, A; Lewis, BS; Coats, AJS; Savarese, G.

Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing

European Heart Journal-Cardiovascular Pharmacotherapy. 2022; 8(2): 187-210 Nº de citas: 13 [doi:10.1093/ehjcvp/pvaa108]

Tamargo, J; Caballero, R; Delpon, E.

Cancer Chemotherapy-Induced Sinus Bradycardia: A Narrative Review of a Forgotten Adverse Effect of Cardiotoxicity

DRUG SAFETY. 2022; 45(2): 101-126 Nº de citas: 6 [doi:10.1007/s40264-021-01132-5]

Fernandez, SN; Toledo, B; Cebrian, J; Perez-Caballero, R; Lopez-Herce, J; Mencia, S.

Continuous Incisional Lidocaine in Pediatric Patients following Open Heart Surgery

Biomed Research International. 2022; 2022: Nº de citas: 3 [doi:10.1155/2022/1403539]

Tamargo J; Caballero R; DELPÓN E.

Sex-related differences in the pharmacological treatment of heart failure

PHARMACOLOGY & THERAPEUTICS. 2022; 229: 107891-107891 Nº de citas: 25 [doi:10.1016/j.pharmthera.2021.107891]

Rubio-Alarcon, M; Camara-Checa, A; Dago, M; Crespo-Garcia, T; Nieto-Marin, P; Marin, M; Merino, JL; Toquero, J; Salguero-Bodes, R; Tamargo, J; Cebrian, J; Delpon, E; Caballero, R; Invest.

Zfhx3 Transcription Factor Represses the Expression of SCN5A Gene and Decreases Sodium Current Density (I-Na)

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021; 22(23): Nº de citas: 9 [doi:10.3390/ijms222313031]

Tamargo, J; Lopez-Sendon, J.

Ranolazine: a better understanding of pathophysiology and patient profile to guide treatment of chronic stable angina

Future Cardiology. 2021; 18(3): 235-251 Nº de citas: 8 [doi:10.2217/fca-2021-0058]

Cebrian, J; Martinez, V; Hernandez, P; Krimer, DB; Fernandez-Nestosa, MJ; Schvartzman, JB.

Two-Dimensional Gel Electrophoresis to Study the Activity of Type IIA Topoisomerases on Plasmid Replication Intermediates

BIOLOGY-BASEL. 2021; 10(11): Nº de citas: 2 [doi:10.3390/biology10111195]

Spivakovsky-Gonzalez, E; Polleys, EJ; Masnovo, C; Cebrian, J; Molina-Vargas, AM; Freudenreich, CH; Mirkin, SM.

Rad9-mediated checkpoint activation is responsible for elevated expansions of GAA repeats in CST-deficient yeast

GENETICS. 2021; 219(2): Nº de citas: 3 [doi:10.1093/genetics/iyab125]

Alonso-Fernandez-Gatta, M; Gallego-Delgado, M; Caballero, R; Villacorta, E; Diaz-Pelaez, E; Garcia-Berroca, B; Crespo-Garcia, T; Plata-Izquierdo, B; Marcos-Vadillo, E; Garcia-Cuenllas, L; Barreiro-Perez, M; Isidoro-Garcia, M; Tamargo-Menendez, J; Delpon, E; Sanchez, PL.

A rare HCN4 variant with combined sinus bradycardia, left atrial dilatation, and hypertrabeculation/left ventricular noncompaction phenotype

REVISTA ESPANOLA DE CARDIOLOGIA. 2021; 74(9): 781-789 Nº de citas: 10 [doi:10.1016/j.recesp.2020.06.037]

Bhatt, DL; Kaski, JC; Delaney, S; Alasnag, M; Andreotti, F; Angiolillo, DJ; Ferro, A; Gorog, DA; Lorenzatti, AJ; Mamas, M; McNeil, J; Nicolau, JC; Steg, PG; Tamargo, J; Tan, D; Valgimigli, M.

Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention

INTERNATIONAL JOURNAL OF CARDIOLOGY. 2021; 337: 1-8 Nº de citas: 7 [doi:10.1016/j.ijcard.2021.05.012]